Compare MTD & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MTD | CBOE |
|---|---|---|
| Founded | 1991 | 1973 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Bankers/Brokers/Service |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6B | 34.2B |
| IPO Year | 1997 | 2010 |
| Metric | MTD | CBOE |
|---|---|---|
| Price | $1,675.74 | $357.65 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 13 | 18 |
| Target Price | ★ $1,737.50 | $360.27 |
| AVG Volume (30 Days) | 156.4K | ★ 1.1M |
| Earning Date | 11-05-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 0.96% |
| EPS Growth | 3.88 | ★ 44.52 |
| EPS | ★ 32.14 | 11.08 |
| Revenue | ★ $4,026,399,000.00 | $2,229,100,000.00 |
| Revenue This Year | $5.90 | N/A |
| Revenue Next Year | $4.38 | $3.53 |
| P/E Ratio | $53.07 | ★ $32.32 |
| Revenue Growth | 3.98 | ★ 239.31 |
| 52 Week Low | $1,023.05 | $227.15 |
| 52 Week High | $1,806.58 | $379.76 |
| Indicator | MTD | CBOE |
|---|---|---|
| Relative Strength Index (RSI) | 48.90 | 59.19 |
| Support Level | $1,239.25 | $273.63 |
| Resistance Level | $1,806.58 | $371.18 |
| Average True Range (ATR) | 48.76 | 10.52 |
| MACD | -12.35 | -1.96 |
| Stochastic Oscillator | 4.76 | 50.44 |
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.